|1.||Ro, Jae Y: 3 articles (01/2009 - 01/2002)|
|2.||Thude, H: 2 articles (02/2010 - 12/2004)|
|3.||Barz, D: 2 articles (02/2010 - 12/2004)|
|4.||Pagel, John M: 2 articles (01/2009 - 08/2008)|
|5.||Gopal, Ajay K: 2 articles (01/2009 - 08/2008)|
|6.||Press, Oliver W: 2 articles (01/2009 - 08/2008)|
|7.||Ayala, Alberto G: 2 articles (01/2009 - 01/2002)|
|8.||Siegel, S E: 2 articles (07/2001 - 05/2000)|
|9.||Kaiser, H E: 2 articles (07/2001 - 05/2000)|
|10.||Bodey, B: 2 articles (07/2001 - 05/2000)|
02/01/2010 - "Immunohistochemical study showed positivity for leukocytic common antigen (CD45), B-cell marker (CD20) and bcl 6. The patient underwent full staging for lymphoma showing no evidence of extra-testicular involvement by lymphoma and no lymph nodes. "
01/01/1999 - "An immunohistochemical study showed that the lymphoma cells were positive for leukocyte common antigen, Epstein-Barr virus, bax. "
09/01/2009 - "The lymphoma cells were positive for leukocyte common antigen, CD79a, CD138, Epstein-Barr virus (EBV) and kappa light chain restriction and negative for CD20, CD3, S100, HMB45 and cytokeratins. "
03/01/1997 - "Lymphoma cells are positive for leukocyte common antigen and L-26, indicating a B cell phenotype. "
11/01/1993 - "No lesions other than lymphoma were leukocyte-common antigen (LCA) positive; all but two lymphomas were LCA positive, while all but one lymphoma were L26 positive. "
|2.||Melanoma (Melanoma, Malignant)
01/01/1994 - "We further observed that in early lesions (< 0.75 mm) of superficial spreading melanoma the vast majority of tumor-infiltrating lymphocytes (TIL) belong to the CD4+ subset and frequently express CD45RA antigens. "
03/15/1988 - "Treatment of melanoma patients with CY plus vaccine resulted in a progressive fall in the proportion of CD4+ T-cells expressing the 2H4 (CD45) antigen, which identifies inducers of suppression. "
11/01/1986 - "Lymphomas and malignant melanomas were excluded by immunohistochemical staining for leukocyte common antigen and S100 protein respectively. "
03/01/2006 - "In total, 74 lesions (12 BN, 12 MDN, 13 RGP-CMM, 26 VGP-CMM, and 11 metastatic melanomas) were examined using immunoperoxidase staining methods and antibodies targeting leukocyte common antigen (LCA+), T (CD3+) and B (CD20+) lymphocytes, and resting cytotoxic T cells (TIA-1+). "
01/01/1996 - "S-100 protein and leukocyte common antigen were helpful in ruling out melanoma and lymphoma. "
|3.||Type 1 Diabetes Mellitus (Autoimmune Diabetes)
12/01/2004 - "A transmembrane protein-tyrosine phosphatase receptor type C (CD45) exon A point mutation (77 C to G) is not associated with the development of type 1 diabetes mellitus in a German population."
02/01/2002 - "A point mutation in the leukocyte common antigen (CD45, C-->G77, exon 4) was investigated in patients with type 1 diabetes (IDDM), patients with Graves' disease and controls. "
01/01/2001 - "The alterations of CD45RA and CD45RO antigens expression on T helper cells in prediabetics suggest the significant role of naive or/and memory CD4+ T cell subsets in the pathogenesis of diabetes type 1. It could be suggested that CD4+CD45RA+/CD4+CD45RO+ ratio could serve as surrogate marker of diabetes type 1 risk development and presumably for estimation of the efficacy of the preventive procedures in subjects at high risk of IDDM, but further prospective studies are needed."
01/01/1999 - "The number of CD4+ T lymphocytes co-expressing CD45RA and CD45RO antigens were statistically higher in the patients with recently diagnosed insulin-dependent diabetes mellitus. "
01/01/1999 - "The aim of the present study was to evaluate the differences between the distribution of memory, naive and recently activated T cells (co-expressing both CD45RA and CD45RO antigens) in the peripheral blood of patients with newly diagnosed Graves' disease and insulin-dependent diabetes mellitus in comparison to healthy controls. "
08/01/2007 - "Leucocyte common antigen (CD45) and CD5 positivity in an "undifferentiated" carcinoma: a potential diagnostic pitfall."
06/01/1998 - "The method is based on the fact that the peripheral blood mononuclear cells (PBMC) that express CD45 antigen are trapped with anti-CD45 conjugated supramagnetic microbeads while the carcinoma cells that do not express CD45 antigen are not trapped and pass through the magnetic fields. "
11/01/1989 - "Expression of MHC class II, interleukin 2 receptor and CD45 antigens on tumour-associated T lymphocytes in colonic carcinoma."
04/01/1989 - "The immunohistochemistry of biopsy specimens pointed to a diagnosis of carcinoma, the tumor cells being cytokeratin positive and leukocyte common antigen (LCA) negative. "
07/01/1988 - "When distinguishing lymphomas from poorly differentiated carcinomas, this method provided much better morphologic differentiation and better demonstration of leukocyte common antigen than keratin staining. "
03/01/1991 - "Leukocyte common antigen and UCHL1 staining was helpful in identifying islet inflammation. "
12/01/2010 - "We quantified, by immunohistochemical means, the PF inflammation in 39 autopsy cases by counting leukocyte common antigen (LCA)-positive cells. "
01/01/2002 - "On immunohistochemistry, leukocyte common antigen was positive, confirming the presence of inflammation. "
01/01/2013 - "Cellular inflammation was quantified by flow-cytometric evaluation of retinal tissue using the myeloid marker CD11b and leukocyte common antigen CD45 to differentiate and quantify CD11b+/CD45low microglia, CD11b+/CD45hi myeloid leukocytes and CD11bneg/CD45hi lymphocytes. "
05/01/2008 - "All of the patients with ulcer had extensive inflammation on bladder biopsy including severe mononuclear cell infiltration, moderate or strong interleukin-6 staining in the urothelium and lamina propria, and leukocyte common antigen staining in more than 10% of the lamina propria. "
|1.||CD45 Antigens (CD45 Antigen)
|4.||S100 Proteins (S 100 Protein)
|6.||von Willebrand Factor
|7.||Biological Markers (Surrogate Marker)
|8.||Pancreatic Elastase (Elastase)
|10.||Ethanol (Ethyl Alcohol)
|2.||Homologous Transplantation (Allograft)
|3.||Heterologous Transplantation (Xenotransplantation)